anmelden
BX Swiss TOP 30 CHF
1.381,84
PKT
+0,86
PKT
+0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.05.14 | Novartis Hold | Deutsche Bank AG | |
| 15.05.14 | Roche buy | Deutsche Bank AG | |
| 14.05.14 | Nestlé overweight | Morgan Stanley | |
| 14.05.14 | UBS buy | UBS AG | |
| 13.05.14 | Nestlé Neutral | HSBC | |
| 13.05.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 13.05.14 | Roche buy | Goldman Sachs Group Inc. | |
| 13.05.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.05.14 | Novartis Hold | Deutsche Bank AG | |
| 12.05.14 | Roche buy | Deutsche Bank AG | |
| 12.05.14 | Swiss Re Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.05.14 | Swiss Re Equal weight | Barclays Capital | |
| 08.05.14 | UBS buy | Société Générale Group S.A. (SG) | |
| 08.05.14 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 08.05.14 | UBS buy | Citigroup Corp. | |
| 08.05.14 | Roche buy | Kelper Cheuvreux | |
| 07.05.14 | Swiss Re verkaufen | DZ-Bank AG | |
| 07.05.14 | UBS buy | Nomura | |
| 07.05.14 | Novartis buy | UBS AG | |
| 07.05.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 07.05.14 | UBS overweight | JP Morgan Chase & Co. | |
| 06.05.14 | UBS buy | UBS AG | |
| 05.05.14 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 05.05.14 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 02.05.14 | Novartis buy | Jefferies & Company Inc. | |
| 02.05.14 | UBS buy | Nomura | |
| 02.05.14 | UBS overweight | Morgan Stanley | |
| 30.04.14 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 30.04.14 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 30.04.14 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 30.04.14 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.14 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 30.04.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 30.04.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 30.04.14 | Swiss Re overweight | Morgan Stanley | |
| 30.04.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 29.04.14 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 29.04.14 | Swiss Re Neutral | BNP PARIBAS | |
| 29.04.14 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 29.04.14 | Novartis Underweight | Morgan Stanley |